Last $0.15 HKD
Change Today +0.005 / 3.52%
Volume 19.3M
897 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 3:01 AM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

wai yuen tong medicine holdi (897) Snapshot

Open
$0.14
Previous Close
$0.14
Day High
$0.15
Day Low
$0.14
52 Week High
07/10/14 - $0.31
52 Week Low
11/21/14 - $0.13
Market Cap
517.0M
Average Volume 10 Days
32.1M
EPS TTM
$0.04
Shares Outstanding
3.5B
EX-Date
07/21/14
P/E TM
3.7x
Dividend
$0.0030
Dividend Yield
2.04%
Current Stock Chart for WAI YUEN TONG MEDICINE HOLDI (897)

Related News

No related news articles were found.

wai yuen tong medicine holdi (897) Related Businessweek News

No Related Businessweek News Found

wai yuen tong medicine holdi (897) Details

Wai Yuen Tong Medicine Holdings Limited, an investment holding company, is engaged in the manufacture, processing, and retail of traditional Chinese medicines under the Wai Yuen Tong brand name primarily in the People’s Republic of China and Hong Kong. The company is also involved in the processing and sale of western pharmaceutical products under the Madame Pearl’s brand name and personal care products under the Pearl’s brand name. In addition, it invests in commercial premises for rental. Wai Yuen Tong Medicine Holdings Limited was founded in 1897 and is headquartered in Kowloon Bay, Hong Kong.

750 Employees
Last Reported Date: 11/19/14
Founded in 1897

wai yuen tong medicine holdi (897) Top Compensated Officers

Managing Director, Executive Director, Member...
Total Annual Compensation: $703.0K
Chairman, Chairman of Executive Committee, Me...
Total Annual Compensation: $703.0K
Compensation as of Fiscal Year 2014.

wai yuen tong medicine holdi (897) Key Developments

Wai Yuen Tong Medicine Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Six Months Ended September 30, 2014

Wai Yuen Tong Medicine Holdings Ltd. reported unaudited consolidated earnings results for the six months ended September 30, 2014. For the period, the company reported revenue of HKD 381,045,000 compared to HKD 410,964,000 a year ago. Profit before tax from continuing operations was HKD 11,718,000 compared to HKD 64,096,000 a year ago. Profit for the period from continuing operations was HKD 11,431,000 compared to HKD 59,945,000 a year ago. Profit for the period was HKD 11,431,000 compared to HKD 59,044,000 a year ago. Profit attributable to Owners of the parent was HKD 11,490,000 compared to HKD 59,080,000 a year ago. Basic and diluted earnings per share from continuing operations were 0.38 cents compared to 2.05 cents a year ago.

Wai Yuen Tong Medicine Holdings Ltd. to Report First Half, 2015 Results on Nov 19, 2014

Wai Yuen Tong Medicine Holdings Ltd. announced that they will report first half, 2015 results on Nov 19, 2014

Wai Yuen Tong Medicine Holdings Ltd., Board Meeting, Nov 19, 2014

Wai Yuen Tong Medicine Holdings Ltd., Board Meeting, Nov 19, 2014. Agenda: To consider the interim results of the company and its subsidiaries for the six months ended 30 September 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
897:HK $0.15 HKD +0.005

897 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 897.
View Industry Companies
 

Industry Analysis

897

Industry Average

Valuation 897 Industry Range
Price/Earnings 3.7x
Price/Sales 0.5x
Price/Book 0.2x
Price/Cash Flow 4.5x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WAI YUEN TONG MEDICINE HOLDI, please visit www.waiyuentong.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.